{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.64","value":"1.6"},{"groupId":"OG001","spread":"0.67","value":"1.5"},{"groupId":"OG002","spread":"0.56","value":"1.6"},{"groupId":"OG003","spread":"0.73","value":"1.6"}]}],"title":"Nausea Frequency"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.59","value":"1.5"},{"groupId":"OG001","spread":"0.62","value":"1.4"},{"groupId":"OG002","spread":"0.61","value":"1.4"},{"groupId":"OG003","spread":"0.73","value":"1.6"}]}],"title":"Nausea Severity"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.96","value":"2.3"},{"groupId":"OG001","spread":"0.94","value":"2.3"},{"groupId":"OG002","spread":"0.98","value":"2.2"},{"groupId":"OG003","spread":"0.91","value":"2.4"}]}],"title":"Appetite"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.99","value":"2.4"},{"groupId":"OG001","spread":"0.88","value":"2.0"},{"groupId":"OG002","spread":"0.89","value":"2.3"},{"groupId":"OG003","spread":"0.91","value":"2.4"}]}],"title":"Insomnia"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.12","value":"2.7"},{"groupId":"OG001","spread":"1.15","value":"2.5"},{"groupId":"OG002","spread":"1.22","value":"2.4"},{"groupId":"OG003","spread":"1.16","value":"2.7"}]}],"title":"Pain Frequency"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.97","value":"2.2"},{"groupId":"OG001","spread":"1.02","value":"2.0"},{"groupId":"OG002","spread":"1.05","value":"2.0"},{"groupId":"OG003","spread":"0.88","value":"2.1"}]}],"title":"Pain Severity"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.82","value":"3.1"},{"groupId":"OG001","spread":"0.94","value":"3.0"},{"groupId":"OG002","spread":"0.97","value":"2.8"},{"groupId":"OG003","spread":"0.91","value":"2.9"}]}],"title":"Fatigue"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.00","value":"2.2"},{"groupId":"OG001","spread":"1.20","value":"2.4"},{"groupId":"OG002","spread":"1.05","value":"2.3"},{"groupId":"OG003","spread":"0.95","value":"2.3"}]}],"title":"Bowel"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.99","value":"2.2"},{"groupId":"OG001","spread":"1.00","value":"2.0"},{"groupId":"OG002","spread":"0.89","value":"1.9"},{"groupId":"OG003","spread":"0.96","value":"2.2"}]}],"title":"Concentration"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.89","value":"2.1"},{"groupId":"OG001","spread":"1.05","value":"2.2"},{"groupId":"OG002","spread":"1.09","value":"2.0"},{"groupId":"OG003","spread":"0.97","value":"2.2"}]}],"title":"Appearance"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.54","value":"1.5"},{"groupId":"OG001","spread":"0.64","value":"1.6"},{"groupId":"OG002","spread":"0.82","value":"1.6"},{"groupId":"OG003","spread":"1.01","value":"1.7"}]}],"title":"Breathing"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.98","value":"2.2"},{"groupId":"OG001","spread":"0.99","value":"2.1"},{"groupId":"OG002","spread":"0.91","value":"2.1"},{"groupId":"OG003","spread":"1.02","value":"2.4"}]}],"title":"Outlook"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.77","value":"1.8"},{"groupId":"OG001","spread":"0.66","value":"1.7"},{"groupId":"OG002","spread":"0.69","value":"1.8"},{"groupId":"OG003","spread":"0.84","value":"2.0"}]}],"title":"Cough"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.64","value":"1.8"},{"groupId":"OG001","spread":"0.79","value":"1.7"},{"groupId":"OG002","spread":"0.65","value":"1.8"},{"groupId":"OG003","spread":"0.90","value":"2.0"}]}],"title":"Depression"}],"denoms":[{"counts":[{"groupId":"OG000","value":"61"},{"groupId":"OG001","value":"60"},{"groupId":"OG002","value":"58"},{"groupId":"OG003","value":"57"}],"units":"Participants"}],"description":"To compare the effects of the 3 different epoetin alfa dosing schedules and a darbepoetin alfa schedule. SDS Scale range: 1 (No Symptom), 5 (Worst Symptom). Average scores across all time points for each item were calculated.","dispersionType":"Standard Deviation","groups":[{"description":"Patients receive Epoetin alfa 40,000 units subcutaneously every week for 15 weeks (15 doses)","id":"OG000","title":"Epoetin Alfa - 40k Weekly"},{"description":"Patients receive Epoetin alfa 80,000 units subcutaneously every 3 weeks for 15 weeks (5 doses)","id":"OG001","title":"Epoetin Alfa - 80k Every 3 Weeks"},{"description":"Patients receive Epoetin alfa 120,000 units subcutaneously every 3 weeks for 15 weeks (5 doses)","id":"OG002","title":"Epoetin Alfa - 120k Every 3 Weeks"},{"description":"Patients receive Darbepoetin alfa 500 micrograms (mcg) subcutaneously every 3 weeks for 15 weeks (5 doses)","id":"OG003","title":"Darbepoetin Alfa - 500 mcg Every 3 Weeks"}],"paramType":"MEAN","populationDescription":"All patients that were evaluable per protocol with QOL data.","reportingStatus":"POSTED","timeFrame":"Weeks 4, 7, 10, 13 and 16","title":"Quality of Life as Measured by Symptom Distress Scale (SDS) Over All Follow-up Evaluations","type":"SECONDARY","unitOfMeasure":"units on a scale"}